nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—asthma—chronic obstructive pulmonary disease	0.32	1	CtDrD
Flunisolide—Prednisone—chronic obstructive pulmonary disease	0.145	0.506	CrCtD
Flunisolide—Prednisolone—chronic obstructive pulmonary disease	0.141	0.494	CrCtD
Flunisolide—SERPINA6—Prednisolone—chronic obstructive pulmonary disease	0.0565	0.385	CbGbCtD
Flunisolide—NR3C1—Prednisolone—chronic obstructive pulmonary disease	0.0264	0.18	CbGbCtD
Flunisolide—NR3C1—Prednisone—chronic obstructive pulmonary disease	0.0249	0.17	CbGbCtD
Flunisolide—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0109	0.0745	CbGbCtD
Flunisolide—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00738	0.0503	CbGbCtD
Flunisolide—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00704	0.048	CbGbCtD
Flunisolide—Ciclesonide—Prednisone—chronic obstructive pulmonary disease	0.00638	0.0322	CrCrCtD
Flunisolide—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00627	0.0428	CbGbCtD
Flunisolide—Ciclesonide—Prednisolone—chronic obstructive pulmonary disease	0.00623	0.0314	CrCrCtD
Flunisolide—Flurandrenolide—Prednisolone—chronic obstructive pulmonary disease	0.00557	0.0281	CrCrCtD
Flunisolide—Prednicarbate—Prednisone—chronic obstructive pulmonary disease	0.00502	0.0253	CrCrCtD
Flunisolide—Prednicarbate—Prednisolone—chronic obstructive pulmonary disease	0.0049	0.0247	CrCrCtD
Flunisolide—Clocortolone—Prednisolone—chronic obstructive pulmonary disease	0.0049	0.0247	CrCrCtD
Flunisolide—Fluocortolone—Prednisone—chronic obstructive pulmonary disease	0.00488	0.0246	CrCrCtD
Flunisolide—Fluocortolone—Prednisolone—chronic obstructive pulmonary disease	0.00476	0.024	CrCrCtD
Flunisolide—Alclometasone—Prednisone—chronic obstructive pulmonary disease	0.00474	0.0239	CrCrCtD
Flunisolide—Fluocinolone Acetonide—Prednisolone—chronic obstructive pulmonary disease	0.00463	0.0233	CrCrCtD
Flunisolide—Alclometasone—Prednisolone—chronic obstructive pulmonary disease	0.00463	0.0233	CrCrCtD
Flunisolide—Amcinonide—Prednisone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Flunisolide—Budesonide—Prednisone—chronic obstructive pulmonary disease	0.00461	0.0233	CrCrCtD
Flunisolide—Amcinonide—Prednisolone—chronic obstructive pulmonary disease	0.0045	0.0227	CrCrCtD
Flunisolide—Budesonide—Prednisolone—chronic obstructive pulmonary disease	0.0045	0.0227	CrCrCtD
Flunisolide—Desonide—Prednisone—chronic obstructive pulmonary disease	0.00449	0.0227	CrCrCtD
Flunisolide—Diflorasone—Prednisone—chronic obstructive pulmonary disease	0.00449	0.0227	CrCrCtD
Flunisolide—Desonide—Prednisolone—chronic obstructive pulmonary disease	0.00439	0.0221	CrCrCtD
Flunisolide—Diflorasone—Prednisolone—chronic obstructive pulmonary disease	0.00439	0.0221	CrCrCtD
Flunisolide—Prednisone—Prednisolone—chronic obstructive pulmonary disease	0.00439	0.0221	CrCrCtD
Flunisolide—Paramethasone—Prednisone—chronic obstructive pulmonary disease	0.00438	0.0221	CrCrCtD
Flunisolide—Paramethasone—Prednisolone—chronic obstructive pulmonary disease	0.00428	0.0216	CrCrCtD
Flunisolide—Desoximetasone—Prednisone—chronic obstructive pulmonary disease	0.00427	0.0216	CrCrCtD
Flunisolide—Fluorometholone—Prednisone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Mometasone—Prednisone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Triamcinolone—Prednisone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Loteprednol—Prednisone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Desoximetasone—Prednisolone—chronic obstructive pulmonary disease	0.00417	0.021	CrCrCtD
Flunisolide—Dexamethasone—Prednisone—chronic obstructive pulmonary disease	0.00408	0.0206	CrCrCtD
Flunisolide—Rimexolone—Prednisone—chronic obstructive pulmonary disease	0.00408	0.0206	CrCrCtD
Flunisolide—Betamethasone—Prednisone—chronic obstructive pulmonary disease	0.00408	0.0206	CrCrCtD
Flunisolide—Loteprednol—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0205	CrCrCtD
Flunisolide—Triamcinolone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0205	CrCrCtD
Flunisolide—Fluorometholone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0205	CrCrCtD
Flunisolide—Mometasone—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0205	CrCrCtD
Flunisolide—Fluprednidene Acetate—Prednisolone—chronic obstructive pulmonary disease	0.00407	0.0205	CrCrCtD
Flunisolide—Betamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00398	0.0201	CrCrCtD
Flunisolide—Dexamethasone—Prednisolone—chronic obstructive pulmonary disease	0.00398	0.0201	CrCrCtD
Flunisolide—Rimexolone—Prednisolone—chronic obstructive pulmonary disease	0.00398	0.0201	CrCrCtD
Flunisolide—Methylprednisolone—Prednisone—chronic obstructive pulmonary disease	0.0039	0.0197	CrCrCtD
Flunisolide—Prednisolone—Prednisone—chronic obstructive pulmonary disease	0.00382	0.0193	CrCrCtD
Flunisolide—Methylprednisolone—Prednisolone—chronic obstructive pulmonary disease	0.00381	0.0192	CrCrCtD
Flunisolide—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00368	0.0251	CbGbCtD
Flunisolide—Hydrocortisone—Prednisone—chronic obstructive pulmonary disease	0.00367	0.0185	CrCrCtD
Flunisolide—Hydrocortisone—Prednisolone—chronic obstructive pulmonary disease	0.00358	0.018	CrCrCtD
Flunisolide—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00348	0.0237	CbGbCtD
Flunisolide—Chills—Salbutamol—chronic obstructive pulmonary disease	8.55e-05	0.00176	CcSEcCtD
Flunisolide—Insomnia—Aminophylline—chronic obstructive pulmonary disease	8.52e-05	0.00175	CcSEcCtD
Flunisolide—Back pain—Formoterol—chronic obstructive pulmonary disease	8.49e-05	0.00175	CcSEcCtD
Flunisolide—Back pain—Arformoterol—chronic obstructive pulmonary disease	8.49e-05	0.00175	CcSEcCtD
Flunisolide—Increased appetite—Prednisolone—chronic obstructive pulmonary disease	8.4e-05	0.00173	CcSEcCtD
Flunisolide—Nausea—Roflumilast—chronic obstructive pulmonary disease	8.39e-05	0.00173	CcSEcCtD
Flunisolide—Cataract—Prednisone—chronic obstructive pulmonary disease	8.3e-05	0.00171	CcSEcCtD
Flunisolide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	8.29e-05	0.00171	CcSEcCtD
Flunisolide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	8.29e-05	0.00171	CcSEcCtD
Flunisolide—Tremor—Arformoterol—chronic obstructive pulmonary disease	8.23e-05	0.00169	CcSEcCtD
Flunisolide—Tremor—Formoterol—chronic obstructive pulmonary disease	8.23e-05	0.00169	CcSEcCtD
Flunisolide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	8.18e-05	0.00169	CcSEcCtD
Flunisolide—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	8.15e-05	0.00168	CcSEcCtD
Flunisolide—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	8.15e-05	0.00168	CcSEcCtD
Flunisolide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	8.12e-05	0.00167	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	8.09e-05	0.00167	CcSEcCtD
Flunisolide—Agitation—Formoterol—chronic obstructive pulmonary disease	8.07e-05	0.00166	CcSEcCtD
Flunisolide—Agitation—Arformoterol—chronic obstructive pulmonary disease	8.07e-05	0.00166	CcSEcCtD
Flunisolide—Tremor—Montelukast—chronic obstructive pulmonary disease	8.06e-05	0.00166	CcSEcCtD
Flunisolide—Insomnia—Tiotropium—chronic obstructive pulmonary disease	8.03e-05	0.00165	CcSEcCtD
Flunisolide—Back pain—Salbutamol—chronic obstructive pulmonary disease	8.02e-05	0.00165	CcSEcCtD
Flunisolide—Malaise—Arformoterol—chronic obstructive pulmonary disease	7.92e-05	0.00163	CcSEcCtD
Flunisolide—Malaise—Formoterol—chronic obstructive pulmonary disease	7.92e-05	0.00163	CcSEcCtD
Flunisolide—Agitation—Montelukast—chronic obstructive pulmonary disease	7.9e-05	0.00163	CcSEcCtD
Flunisolide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	7.82e-05	0.00161	CcSEcCtD
Flunisolide—Tremor—Salbutamol—chronic obstructive pulmonary disease	7.77e-05	0.0016	CcSEcCtD
Flunisolide—Palpitations—Arformoterol—chronic obstructive pulmonary disease	7.76e-05	0.0016	CcSEcCtD
Flunisolide—Palpitations—Formoterol—chronic obstructive pulmonary disease	7.76e-05	0.0016	CcSEcCtD
Flunisolide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	7.7e-05	0.00159	CcSEcCtD
Flunisolide—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	7.69e-05	0.00158	CcSEcCtD
Flunisolide—Cough—Arformoterol—chronic obstructive pulmonary disease	7.66e-05	0.00158	CcSEcCtD
Flunisolide—Cough—Formoterol—chronic obstructive pulmonary disease	7.66e-05	0.00158	CcSEcCtD
Flunisolide—Agitation—Salbutamol—chronic obstructive pulmonary disease	7.62e-05	0.00157	CcSEcCtD
Flunisolide—Palpitations—Montelukast—chronic obstructive pulmonary disease	7.6e-05	0.00157	CcSEcCtD
Flunisolide—Constipation—Tiotropium—chronic obstructive pulmonary disease	7.59e-05	0.00156	CcSEcCtD
Flunisolide—Hypertension—Formoterol—chronic obstructive pulmonary disease	7.58e-05	0.00156	CcSEcCtD
Flunisolide—Hypertension—Arformoterol—chronic obstructive pulmonary disease	7.58e-05	0.00156	CcSEcCtD
Flunisolide—Cough—Montelukast—chronic obstructive pulmonary disease	7.5e-05	0.00155	CcSEcCtD
Flunisolide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	7.48e-05	0.00154	CcSEcCtD
Flunisolide—Malaise—Salbutamol—chronic obstructive pulmonary disease	7.48e-05	0.00154	CcSEcCtD
Flunisolide—Chest pain—Formoterol—chronic obstructive pulmonary disease	7.47e-05	0.00154	CcSEcCtD
Flunisolide—Myalgia—Formoterol—chronic obstructive pulmonary disease	7.47e-05	0.00154	CcSEcCtD
Flunisolide—Chest pain—Arformoterol—chronic obstructive pulmonary disease	7.47e-05	0.00154	CcSEcCtD
Flunisolide—Myalgia—Arformoterol—chronic obstructive pulmonary disease	7.47e-05	0.00154	CcSEcCtD
Flunisolide—Anxiety—Formoterol—chronic obstructive pulmonary disease	7.45e-05	0.00153	CcSEcCtD
Flunisolide—Anxiety—Arformoterol—chronic obstructive pulmonary disease	7.45e-05	0.00153	CcSEcCtD
Flunisolide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	7.45e-05	0.00153	CcSEcCtD
Flunisolide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	7.44e-05	0.00153	CcSEcCtD
Flunisolide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	7.44e-05	0.00153	CcSEcCtD
Flunisolide—Syncope—Salbutamol—chronic obstructive pulmonary disease	7.43e-05	0.00153	CcSEcCtD
Flunisolide—Discomfort—Arformoterol—chronic obstructive pulmonary disease	7.39e-05	0.00152	CcSEcCtD
Flunisolide—Discomfort—Formoterol—chronic obstructive pulmonary disease	7.39e-05	0.00152	CcSEcCtD
Flunisolide—Palpitations—Salbutamol—chronic obstructive pulmonary disease	7.33e-05	0.00151	CcSEcCtD
Flunisolide—Myalgia—Montelukast—chronic obstructive pulmonary disease	7.32e-05	0.00151	CcSEcCtD
Flunisolide—Anxiety—Montelukast—chronic obstructive pulmonary disease	7.3e-05	0.0015	CcSEcCtD
Flunisolide—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	7.29e-05	0.0015	CcSEcCtD
Flunisolide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	7.26e-05	0.0015	CcSEcCtD
Flunisolide—Cough—Salbutamol—chronic obstructive pulmonary disease	7.23e-05	0.00149	CcSEcCtD
Flunisolide—Oedema—Formoterol—chronic obstructive pulmonary disease	7.17e-05	0.00148	CcSEcCtD
Flunisolide—Oedema—Arformoterol—chronic obstructive pulmonary disease	7.17e-05	0.00148	CcSEcCtD
Flunisolide—Hypertension—Salbutamol—chronic obstructive pulmonary disease	7.16e-05	0.00147	CcSEcCtD
Flunisolide—Infection—Arformoterol—chronic obstructive pulmonary disease	7.12e-05	0.00147	CcSEcCtD
Flunisolide—Infection—Formoterol—chronic obstructive pulmonary disease	7.12e-05	0.00147	CcSEcCtD
Flunisolide—Myalgia—Salbutamol—chronic obstructive pulmonary disease	7.06e-05	0.00145	CcSEcCtD
Flunisolide—Chest pain—Salbutamol—chronic obstructive pulmonary disease	7.06e-05	0.00145	CcSEcCtD
Flunisolide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	7.05e-05	0.00145	CcSEcCtD
Flunisolide—Anxiety—Salbutamol—chronic obstructive pulmonary disease	7.03e-05	0.00145	CcSEcCtD
Flunisolide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	7.02e-05	0.00145	CcSEcCtD
Flunisolide—Oedema—Montelukast—chronic obstructive pulmonary disease	7.02e-05	0.00145	CcSEcCtD
Flunisolide—Tachycardia—Formoterol—chronic obstructive pulmonary disease	6.99e-05	0.00144	CcSEcCtD
Flunisolide—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	6.99e-05	0.00144	CcSEcCtD
Flunisolide—Discomfort—Salbutamol—chronic obstructive pulmonary disease	6.97e-05	0.00144	CcSEcCtD
Flunisolide—Infection—Montelukast—chronic obstructive pulmonary disease	6.97e-05	0.00144	CcSEcCtD
Flunisolide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	6.94e-05	0.00143	CcSEcCtD
Flunisolide—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.00142	CcSEcCtD
Flunisolide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	6.87e-05	0.00142	CcSEcCtD
Flunisolide—Oedema—Salbutamol—chronic obstructive pulmonary disease	6.77e-05	0.00139	CcSEcCtD
Flunisolide—Infection—Salbutamol—chronic obstructive pulmonary disease	6.72e-05	0.00138	CcSEcCtD
Flunisolide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	6.66e-05	0.00137	CcSEcCtD
Flunisolide—Shock—Salbutamol—chronic obstructive pulmonary disease	6.66e-05	0.00137	CcSEcCtD
Flunisolide—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	6.6e-05	0.00136	CcSEcCtD
Flunisolide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	6.54e-05	0.00135	CcSEcCtD
Flunisolide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	6.54e-05	0.00135	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	6.53e-05	0.00134	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	6.53e-05	0.00134	CcSEcCtD
Flunisolide—Insomnia—Arformoterol—chronic obstructive pulmonary disease	6.48e-05	0.00133	CcSEcCtD
Flunisolide—Insomnia—Formoterol—chronic obstructive pulmonary disease	6.48e-05	0.00133	CcSEcCtD
Flunisolide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	6.44e-05	0.00133	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	6.39e-05	0.00132	CcSEcCtD
Flunisolide—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	6.39e-05	0.00132	CcSEcCtD
Flunisolide—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	6.39e-05	0.00132	CcSEcCtD
Flunisolide—Insomnia—Montelukast—chronic obstructive pulmonary disease	6.35e-05	0.00131	CcSEcCtD
Flunisolide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	6.31e-05	0.0013	CcSEcCtD
Flunisolide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	6.31e-05	0.0013	CcSEcCtD
Flunisolide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	6.28e-05	0.00129	CcSEcCtD
Flunisolide—Injury—Prednisone—chronic obstructive pulmonary disease	6.24e-05	0.00129	CcSEcCtD
Flunisolide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	6.23e-05	0.00128	CcSEcCtD
Flunisolide—Weight increased—Prednisolone—chronic obstructive pulmonary disease	6.21e-05	0.00128	CcSEcCtD
Flunisolide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	6.18e-05	0.00127	CcSEcCtD
Flunisolide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	6.18e-05	0.00127	CcSEcCtD
Flunisolide—Fatigue—Formoterol—chronic obstructive pulmonary disease	6.18e-05	0.00127	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	6.16e-05	0.00127	CcSEcCtD
Flunisolide—Pain—Arformoterol—chronic obstructive pulmonary disease	6.13e-05	0.00126	CcSEcCtD
Flunisolide—Constipation—Arformoterol—chronic obstructive pulmonary disease	6.13e-05	0.00126	CcSEcCtD
Flunisolide—Pain—Formoterol—chronic obstructive pulmonary disease	6.13e-05	0.00126	CcSEcCtD
Flunisolide—Constipation—Formoterol—chronic obstructive pulmonary disease	6.13e-05	0.00126	CcSEcCtD
Flunisolide—Insomnia—Salbutamol—chronic obstructive pulmonary disease	6.12e-05	0.00126	CcSEcCtD
Flunisolide—Increased appetite—Prednisone—chronic obstructive pulmonary disease	6.11e-05	0.00126	CcSEcCtD
Flunisolide—Fatigue—Montelukast—chronic obstructive pulmonary disease	6.05e-05	0.00125	CcSEcCtD
Flunisolide—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	6.03e-05	0.00124	CcSEcCtD
Flunisolide—Pain—Montelukast—chronic obstructive pulmonary disease	6e-05	0.00124	CcSEcCtD
Flunisolide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	5.99e-05	0.00123	CcSEcCtD
Flunisolide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	5.96e-05	0.00123	CcSEcCtD
Flunisolide—Rash—Aminophylline—chronic obstructive pulmonary disease	5.94e-05	0.00122	CcSEcCtD
Flunisolide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	5.93e-05	0.00122	CcSEcCtD
Flunisolide—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	5.91e-05	0.00122	CcSEcCtD
Flunisolide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	5.9e-05	0.00122	CcSEcCtD
Flunisolide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	5.9e-05	0.00122	CcSEcCtD
Flunisolide—Headache—Aminophylline—chronic obstructive pulmonary disease	5.9e-05	0.00121	CcSEcCtD
Flunisolide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	5.88e-05	0.00121	CcSEcCtD
Flunisolide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	5.87e-05	0.00121	CcSEcCtD
Flunisolide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	5.86e-05	0.00121	CcSEcCtD
Flunisolide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	5.86e-05	0.00121	CcSEcCtD
Flunisolide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	5.83e-05	0.0012	CcSEcCtD
Flunisolide—Pain—Salbutamol—chronic obstructive pulmonary disease	5.79e-05	0.00119	CcSEcCtD
Flunisolide—Constipation—Salbutamol—chronic obstructive pulmonary disease	5.79e-05	0.00119	CcSEcCtD
Flunisolide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	5.74e-05	0.00118	CcSEcCtD
Flunisolide—Urticaria—Formoterol—chronic obstructive pulmonary disease	5.69e-05	0.00117	CcSEcCtD
Flunisolide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	5.69e-05	0.00117	CcSEcCtD
Flunisolide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	5.66e-05	0.00117	CcSEcCtD
Flunisolide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	5.66e-05	0.00117	CcSEcCtD
Flunisolide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	5.66e-05	0.00117	CcSEcCtD
Flunisolide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	5.66e-05	0.00117	CcSEcCtD
Flunisolide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	5.65e-05	0.00116	CcSEcCtD
Flunisolide—Rash—Tiotropium—chronic obstructive pulmonary disease	5.6e-05	0.00115	CcSEcCtD
Flunisolide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	5.59e-05	0.00115	CcSEcCtD
Flunisolide—Nausea—Aminophylline—chronic obstructive pulmonary disease	5.59e-05	0.00115	CcSEcCtD
Flunisolide—Urticaria—Montelukast—chronic obstructive pulmonary disease	5.58e-05	0.00115	CcSEcCtD
Flunisolide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	5.58e-05	0.00115	CcSEcCtD
Flunisolide—Headache—Tiotropium—chronic obstructive pulmonary disease	5.56e-05	0.00115	CcSEcCtD
Flunisolide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	5.55e-05	0.00114	CcSEcCtD
Flunisolide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	5.55e-05	0.00114	CcSEcCtD
Flunisolide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	5.53e-05	0.00114	CcSEcCtD
Flunisolide—Irritability—Prednisone—chronic obstructive pulmonary disease	5.48e-05	0.00113	CcSEcCtD
Flunisolide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	5.38e-05	0.00111	CcSEcCtD
Flunisolide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	5.35e-05	0.0011	CcSEcCtD
Flunisolide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	5.35e-05	0.0011	CcSEcCtD
Flunisolide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	5.28e-05	0.00109	CcSEcCtD
Flunisolide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	5.28e-05	0.00109	CcSEcCtD
Flunisolide—Nausea—Tiotropium—chronic obstructive pulmonary disease	5.27e-05	0.00109	CcSEcCtD
Flunisolide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	5.17e-05	0.00107	CcSEcCtD
Flunisolide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	5.14e-05	0.00106	CcSEcCtD
Flunisolide—Asthenia—Formoterol—chronic obstructive pulmonary disease	5.14e-05	0.00106	CcSEcCtD
Flunisolide—Pruritus—Formoterol—chronic obstructive pulmonary disease	5.07e-05	0.00104	CcSEcCtD
Flunisolide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	5.07e-05	0.00104	CcSEcCtD
Flunisolide—Asthenia—Montelukast—chronic obstructive pulmonary disease	5.04e-05	0.00104	CcSEcCtD
Flunisolide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	4.99e-05	0.00103	CcSEcCtD
Flunisolide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	4.98e-05	0.00103	CcSEcCtD
Flunisolide—Pruritus—Montelukast—chronic obstructive pulmonary disease	4.97e-05	0.00102	CcSEcCtD
Flunisolide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	4.9e-05	0.00101	CcSEcCtD
Flunisolide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	4.9e-05	0.00101	CcSEcCtD
Flunisolide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	4.85e-05	0.001	CcSEcCtD
Flunisolide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	4.8e-05	0.000989	CcSEcCtD
Flunisolide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	4.79e-05	0.000986	CcSEcCtD
Flunisolide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	4.74e-05	0.000976	CcSEcCtD
Flunisolide—Dizziness—Formoterol—chronic obstructive pulmonary disease	4.74e-05	0.000976	CcSEcCtD
Flunisolide—Dizziness—Montelukast—chronic obstructive pulmonary disease	4.64e-05	0.000956	CcSEcCtD
Flunisolide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	4.63e-05	0.000954	CcSEcCtD
Flunisolide—Vomiting—Formoterol—chronic obstructive pulmonary disease	4.56e-05	0.000938	CcSEcCtD
Flunisolide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	4.56e-05	0.000938	CcSEcCtD
Flunisolide—Rash—Formoterol—chronic obstructive pulmonary disease	4.52e-05	0.000931	CcSEcCtD
Flunisolide—Rash—Arformoterol—chronic obstructive pulmonary disease	4.52e-05	0.000931	CcSEcCtD
Flunisolide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	4.51e-05	0.00093	CcSEcCtD
Flunisolide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	4.51e-05	0.00093	CcSEcCtD
Flunisolide—Weight increased—Prednisone—chronic obstructive pulmonary disease	4.51e-05	0.00093	CcSEcCtD
Flunisolide—Headache—Formoterol—chronic obstructive pulmonary disease	4.49e-05	0.000925	CcSEcCtD
Flunisolide—Headache—Arformoterol—chronic obstructive pulmonary disease	4.49e-05	0.000925	CcSEcCtD
Flunisolide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	4.48e-05	0.000923	CcSEcCtD
Flunisolide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	4.47e-05	0.000922	CcSEcCtD
Flunisolide—Vomiting—Montelukast—chronic obstructive pulmonary disease	4.46e-05	0.000919	CcSEcCtD
Flunisolide—Rash—Montelukast—chronic obstructive pulmonary disease	4.43e-05	0.000912	CcSEcCtD
Flunisolide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	4.42e-05	0.000911	CcSEcCtD
Flunisolide—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	4.41e-05	0.000909	CcSEcCtD
Flunisolide—Headache—Montelukast—chronic obstructive pulmonary disease	4.4e-05	0.000906	CcSEcCtD
Flunisolide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	4.3e-05	0.000886	CcSEcCtD
Flunisolide—Malaise—Prednisolone—chronic obstructive pulmonary disease	4.29e-05	0.000883	CcSEcCtD
Flunisolide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	4.27e-05	0.00088	CcSEcCtD
Flunisolide—Rash—Salbutamol—chronic obstructive pulmonary disease	4.27e-05	0.000879	CcSEcCtD
Flunisolide—Syncope—Prednisolone—chronic obstructive pulmonary disease	4.26e-05	0.000878	CcSEcCtD
Flunisolide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	4.26e-05	0.000878	CcSEcCtD
Flunisolide—Nausea—Arformoterol—chronic obstructive pulmonary disease	4.26e-05	0.000877	CcSEcCtD
Flunisolide—Nausea—Formoterol—chronic obstructive pulmonary disease	4.26e-05	0.000877	CcSEcCtD
Flunisolide—Headache—Salbutamol—chronic obstructive pulmonary disease	4.24e-05	0.000873	CcSEcCtD
Flunisolide—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	4.18e-05	0.000861	CcSEcCtD
Flunisolide—Nausea—Montelukast—chronic obstructive pulmonary disease	4.17e-05	0.000859	CcSEcCtD
Flunisolide—Hypertension—Prednisolone—chronic obstructive pulmonary disease	4.11e-05	0.000846	CcSEcCtD
Flunisolide—Nausea—Salbutamol—chronic obstructive pulmonary disease	4.02e-05	0.000828	CcSEcCtD
Flunisolide—Discomfort—Prednisolone—chronic obstructive pulmonary disease	4e-05	0.000824	CcSEcCtD
Flunisolide—Oedema—Prednisolone—chronic obstructive pulmonary disease	3.88e-05	0.000799	CcSEcCtD
Flunisolide—Shock—Prednisolone—chronic obstructive pulmonary disease	3.82e-05	0.000786	CcSEcCtD
Flunisolide—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	3.79e-05	0.00078	CcSEcCtD
Flunisolide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	3.75e-05	0.000773	CcSEcCtD
Flunisolide—Insomnia—Prednisolone—chronic obstructive pulmonary disease	3.51e-05	0.000723	CcSEcCtD
Flunisolide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	3.46e-05	0.000712	CcSEcCtD
Flunisolide—Pain—Prednisolone—chronic obstructive pulmonary disease	3.32e-05	0.000684	CcSEcCtD
Flunisolide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	3.26e-05	0.000671	CcSEcCtD
Flunisolide—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	3.21e-05	0.00066	CcSEcCtD
Flunisolide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	3.2e-05	0.000659	CcSEcCtD
Flunisolide—Agitation—Prednisone—chronic obstructive pulmonary disease	3.18e-05	0.000654	CcSEcCtD
Flunisolide—Malaise—Prednisone—chronic obstructive pulmonary disease	3.12e-05	0.000642	CcSEcCtD
Flunisolide—Vertigo—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000639	CcSEcCtD
Flunisolide—Syncope—Prednisone—chronic obstructive pulmonary disease	3.1e-05	0.000638	CcSEcCtD
Flunisolide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	3.08e-05	0.000635	CcSEcCtD
Flunisolide—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	3.04e-05	0.000626	CcSEcCtD
Flunisolide—Hypertension—Prednisone—chronic obstructive pulmonary disease	2.98e-05	0.000614	CcSEcCtD
Flunisolide—Myalgia—Prednisone—chronic obstructive pulmonary disease	2.94e-05	0.000606	CcSEcCtD
Flunisolide—Anxiety—Prednisone—chronic obstructive pulmonary disease	2.93e-05	0.000604	CcSEcCtD
Flunisolide—Discomfort—Prednisone—chronic obstructive pulmonary disease	2.91e-05	0.000599	CcSEcCtD
Flunisolide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	2.86e-05	0.000589	CcSEcCtD
Flunisolide—Oedema—Prednisone—chronic obstructive pulmonary disease	2.82e-05	0.000581	CcSEcCtD
Flunisolide—Infection—Prednisone—chronic obstructive pulmonary disease	2.8e-05	0.000577	CcSEcCtD
Flunisolide—Shock—Prednisone—chronic obstructive pulmonary disease	2.77e-05	0.000571	CcSEcCtD
Flunisolide—Tachycardia—Prednisone—chronic obstructive pulmonary disease	2.75e-05	0.000567	CcSEcCtD
Flunisolide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	2.73e-05	0.000562	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	2.57e-05	0.000529	CcSEcCtD
Flunisolide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	2.57e-05	0.000529	CcSEcCtD
Flunisolide—Insomnia—Prednisone—chronic obstructive pulmonary disease	2.55e-05	0.000525	CcSEcCtD
Flunisolide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	2.48e-05	0.000511	CcSEcCtD
Flunisolide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	2.45e-05	0.000505	CcSEcCtD
Flunisolide—Rash—Prednisolone—chronic obstructive pulmonary disease	2.45e-05	0.000504	CcSEcCtD
Flunisolide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	2.44e-05	0.000504	CcSEcCtD
Flunisolide—Fatigue—Prednisone—chronic obstructive pulmonary disease	2.43e-05	0.000501	CcSEcCtD
Flunisolide—Headache—Prednisolone—chronic obstructive pulmonary disease	2.43e-05	0.000501	CcSEcCtD
Flunisolide—Constipation—Prednisone—chronic obstructive pulmonary disease	2.41e-05	0.000497	CcSEcCtD
Flunisolide—CYP3A4—Lidocaine metabolism—CYP1A2—chronic obstructive pulmonary disease	2.37e-05	0.1	CbGpPWpGaD
Flunisolide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	2.32e-05	0.000479	CcSEcCtD
Flunisolide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	2.31e-05	0.000475	CcSEcCtD
Flunisolide—Nausea—Prednisolone—chronic obstructive pulmonary disease	2.31e-05	0.000475	CcSEcCtD
Flunisolide—Urticaria—Prednisone—chronic obstructive pulmonary disease	2.24e-05	0.000461	CcSEcCtD
Flunisolide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000459	CcSEcCtD
Flunisolide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	2.23e-05	0.000459	CcSEcCtD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—EPHX1—chronic obstructive pulmonary disease	2.1e-05	0.0887	CbGpPWpGaD
Flunisolide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	2.08e-05	0.000428	CcSEcCtD
Flunisolide—Asthenia—Prednisone—chronic obstructive pulmonary disease	2.02e-05	0.000417	CcSEcCtD
Flunisolide—Pruritus—Prednisone—chronic obstructive pulmonary disease	2e-05	0.000411	CcSEcCtD
Flunisolide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	1.93e-05	0.000397	CcSEcCtD
Flunisolide—Dizziness—Prednisone—chronic obstructive pulmonary disease	1.86e-05	0.000384	CcSEcCtD
Flunisolide—Vomiting—Prednisone—chronic obstructive pulmonary disease	1.79e-05	0.000369	CcSEcCtD
Flunisolide—Rash—Prednisone—chronic obstructive pulmonary disease	1.78e-05	0.000366	CcSEcCtD
Flunisolide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	1.78e-05	0.000366	CcSEcCtD
Flunisolide—Headache—Prednisone—chronic obstructive pulmonary disease	1.77e-05	0.000364	CcSEcCtD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—EPHX1—chronic obstructive pulmonary disease	1.72e-05	0.0726	CbGpPWpGaD
Flunisolide—Nausea—Prednisone—chronic obstructive pulmonary disease	1.68e-05	0.000345	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	1.07e-05	0.0452	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—chronic obstructive pulmonary disease	8.71e-06	0.0368	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—chronic obstructive pulmonary disease	6.68e-06	0.0282	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—LEP—chronic obstructive pulmonary disease	6.64e-06	0.0281	CbGpPWpGaD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—chronic obstructive pulmonary disease	5.18e-06	0.0219	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL13—chronic obstructive pulmonary disease	4.5e-06	0.019	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	4.5e-06	0.019	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	4.09e-06	0.0173	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—chronic obstructive pulmonary disease	3.92e-06	0.0166	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	3.76e-06	0.0159	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—HDAC2—chronic obstructive pulmonary disease	3.76e-06	0.0159	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—HDAC2—chronic obstructive pulmonary disease	3.72e-06	0.0157	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	3.62e-06	0.0153	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—SERPINE1—chronic obstructive pulmonary disease	3.44e-06	0.0145	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	3.27e-06	0.0138	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EDN1—chronic obstructive pulmonary disease	3.24e-06	0.0137	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL10—chronic obstructive pulmonary disease	3.2e-06	0.0135	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	3.14e-06	0.0133	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—TNF—chronic obstructive pulmonary disease	3.07e-06	0.013	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—chronic obstructive pulmonary disease	2.99e-06	0.0126	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.97e-06	0.0126	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—chronic obstructive pulmonary disease	2.85e-06	0.012	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	2.73e-06	0.0116	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP1—chronic obstructive pulmonary disease	2.72e-06	0.0115	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL13—chronic obstructive pulmonary disease	2.69e-06	0.0114	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—PLAU—chronic obstructive pulmonary disease	2.67e-06	0.0113	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	2.63e-06	0.0111	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—ADIPOQ—chronic obstructive pulmonary disease	2.58e-06	0.0109	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—SERPINE1—chronic obstructive pulmonary disease	2.5e-06	0.0106	CbGpPWpGaD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	2.48e-06	0.0105	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	2.46e-06	0.0104	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—chronic obstructive pulmonary disease	2.43e-06	0.0103	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—chronic obstructive pulmonary disease	2.4e-06	0.0101	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A2—chronic obstructive pulmonary disease	1.93e-06	0.00817	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—chronic obstructive pulmonary disease	1.84e-06	0.00777	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—CXCL8—chronic obstructive pulmonary disease	1.75e-06	0.00739	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL10—chronic obstructive pulmonary disease	1.68e-06	0.00712	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—LEP—chronic obstructive pulmonary disease	1.6e-06	0.00678	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	1.6e-06	0.00676	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—chronic obstructive pulmonary disease	1.58e-06	0.00669	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	1.56e-06	0.00661	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	1.54e-06	0.00652	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—chronic obstructive pulmonary disease	1.54e-06	0.00651	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HTR2A—chronic obstructive pulmonary disease	1.49e-06	0.0063	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A1—chronic obstructive pulmonary disease	1.4e-06	0.00594	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—TGFB1—chronic obstructive pulmonary disease	1.33e-06	0.00564	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TGFB1—chronic obstructive pulmonary disease	1.3e-06	0.00551	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	1.27e-06	0.00535	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	1.26e-06	0.00532	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	1.14e-06	0.0048	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	1.12e-06	0.00474	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—chronic obstructive pulmonary disease	1.07e-06	0.00454	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	1.01e-06	0.00426	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—chronic obstructive pulmonary disease	9.82e-07	0.00415	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—chronic obstructive pulmonary disease	9.46e-07	0.004	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	9.21e-07	0.00389	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	9.2e-07	0.00389	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	8.84e-07	0.00374	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—chronic obstructive pulmonary disease	8.66e-07	0.00366	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	8.1e-07	0.00342	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	8e-07	0.00338	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	7.94e-07	0.00336	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	7.48e-07	0.00316	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—TNF—chronic obstructive pulmonary disease	7.42e-07	0.00314	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	6.73e-07	0.00284	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	6.64e-07	0.00281	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	6.41e-07	0.00271	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—chronic obstructive pulmonary disease	5.99e-07	0.00253	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	5.61e-07	0.00237	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	5.53e-07	0.00234	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	5.17e-07	0.00219	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	5.16e-07	0.00218	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	5.09e-07	0.00215	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	4.89e-07	0.00207	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CTGF—chronic obstructive pulmonary disease	4.85e-07	0.00205	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	4.82e-07	0.00204	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	4.59e-07	0.00194	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HDAC2—chronic obstructive pulmonary disease	4.52e-07	0.00191	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	3.93e-07	0.00166	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.61e-07	0.0011	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	2.53e-07	0.00107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.36e-07	0.000996	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	2.21e-07	0.000935	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.38e-07	0.000585	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.37e-07	0.000579	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.25e-07	0.000528	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.15e-07	0.000486	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.6e-08	0.000406	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.46e-08	0.0004	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.82e-08	0.000373	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.36e-08	0.000353	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	5.68e-08	0.00024	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	5.44e-08	0.00023	CbGpPWpGaD
